RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Abbott Diagnostics - Product Pipeline Analysis
Mar 2011 - 66 pages - $750
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Alfa Wassermann, Inc. - Product Pipeline Analysis
Mar 2011 - 18 pages - $750
BAE Systems Integrated System Technologies Limited - Company Capsule
Aug 2011 - 8 pages - $75
Siemens Healthcare - Product Pipeline Analysis
May 2011 - 98 pages - $750
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Company Financials: Acorda Therapeutics, Inc.
Jan 2010 - $75
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Assay systems del
Therapeutic target
Central Nervous System del
Development phase
Phase II del

Browse By

Therapeutic target
Age-related disorders (other)
Amyotrophic lateral sclerosis
CNS (other)
Neurodegenerative disorders
Neurological
Pain
Psychiatric
Subarachnoid hemorrhage
Traumatic brain injury

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us